
Publication
Essential Corporate News – Week ending 23 May 2025
The Companies and Limited Liability Partnerships (Annotation) Regulations 2025 and an accompanying Explanatory Memorandum were published on 14 May 2025.
Global | Publication | February 2018
Houses in multiple occupation (HMOs) are one of the main forms of housing in the private rented sector for those on low income or benefits.
Certain types of HMOs are subject to mandatory licensing by local housing authorities. In general terms they are HMOs that comprise 3 storeys or more and are occupied by 5 or more people in 2 or more separate households.
Legislation was laid before parliament on 23 February 2018 to extend the scope of mandatory HMO licensing so that it applies to most HMOs occupied by 5 persons or more in 2 or more households regardless of the number of storeys. It is estimated that this will result in an additional 177,000 HMOs being subject to mandatory licensing in England.
The change will come into force on 1 October 2018. Landlords of HMOs falling within the extended definition who fail to apply for a licence by that date will commit a criminal offence.
Confused by HMOs? You are not alone. The government intends to publish a toolkit for landlords to help identify whether an HMO licence is required.
For further information please contact Sian Skerratt-Williams or your usual contact at Norton Rose Fulbright.
Publication
The Companies and Limited Liability Partnerships (Annotation) Regulations 2025 and an accompanying Explanatory Memorandum were published on 14 May 2025.
Blog
In this our latest blog on Mansion House reforms, we turn from DC to DB, and more specifically to those record surpluses that many schemes are now enjoying.
Publication
The Regulator’s annual funding statement for private sector DB schemes was published on April 29, 2025. It is the first such statement since the new DB funding regime came into force from September 22, 2024, onwards.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025